Ebenezer Idowu O. Ajayi

Dr. Ebenezer Idowu O. Ajayi


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Plant Physiology and Biochemistry
Verified
Journal Article
Closed access
ALAzeez Luqmon
Azeez Luqmon
ALAgbaje Lateef
Agbaje Lateef
AWAbideen A. Wahab
Abideen A. Wahab
MRMuhammed A. Rufai
Muhammed A. Rufai
ASAmadu K. Salau
Amadu K. Salau
BABasirat Adebisi
Basirat Adebisi

23 November 2019 in Nutrition
Verified
Journal Article
Closed access
MVMarianela Vara-Messler
Marianela Vara-Messler
JMJorge Humberto Mukdsi
Jorge Humberto Mukdsi
NONatalia I. Osieki
Natalia I. Osieki
EBEvangelina Benizio
Evangelina Benizio
GRGastón M. Repossi
Gastón M. Repossi
NGNestor Garcia
Nestor Garcia

1 January 2023 in Infection & Chemotherapy
Verified
Journal Article
Open access
AUAbdulrasheed Usman
Abdulrasheed Usman
OBOlayemi Balogun
Olayemi Balogun
Bukhari Isah ShuaibBukhari Isah Shuaib
Bukhari Isah Shuaib
BMBolanle O. P. Musa
Bolanle O. P. Musa
AYAminu Abba Yusuf
Aminu Abba Yusuf
EAEbenezer Idowu O. Ajayi
Ebenezer Idowu O. Ajayi
Usman A, et al. Infect Chemother. 2023 Dec;55:e55. https://doi.org/10.3947/ic.2023.0080

17 February 2016 in African Journal of Traditional, Complementary and Alternative Medicines
Verified
Journal Article
Closed access
PDF file
EAEbenezer Idowu O. Ajayi
Ebenezer Idowu O. Ajayi
GPGbemisola Popoola
Gbemisola Popoola
EOEdward Ojediran
Edward Ojediran
Wound healing potential of Nuclea latifolia and Manihot esculenta leaf extracts in Type 1 diabetic rats

10 January 2016 in International Journal of Biochemistry Research & Review
Verified
Journal Article
Open access
EAEbenezer Idowu O. Ajayi
Ebenezer Idowu O. Ajayi
EMEmmanuel Modo
Emmanuel Modo
AAAdetayo Adebamowo
Adetayo Adebamowo
UBUttam Banerjee
Uttam Banerjee
OTOlumide Tewe
Olumide Tewe
OOOlufunso Olorunsogo
Olufunso Olorunsogo
The modulatory effect of different concentrations of ethanol extract of matured leaves of M. esculenta, Crantz at 200, 600, 1000 and 1400 µg/ml was investigated in vitro on mitochondrial membrane permeability transition pore in liver, kidney and heart of diabetic animals in the absence and presence of 20 µM exogenous Ca2+. The extract at these concentrations had no significant (p< 0.05) effect on mitochondrial membrane permeability transition (MPT) pore of the three organs in the absence of Ca2+. However, in the presence of Ca2+, the extract exhibited significant (p< 0.05) inhibition of mitochondrial membrane transition pore opening: liver by 62.66%, 42.47%, 22.44% and 17.63% at 1400, 1000, 600, and 200 µg/ml, respectively. In the heart, inhibition of MMPT pore opening was by 92.86%, 71.43%, 64.29% and 57.14% at 200, 600, 1400, and 1000 µg/ml, respectively. In the kidney, the extract also inhibited mitochondrial membrane transition pore opening in a concentration-dependent manner by 92.65%, 91.18%, 89.71% and 72.06% at 1400, 1000, 600, and 200 µg/ml, respectively. Caspase-3 activity in vitro was also reduced with increasing extract concentrations; thus confirming that the extract inhibits MMPT pore opening in the presence of Ca2+. The extract may be able to protect these organs against damage, resulting from Ca2+ overload that may trigger cell death, and as such it may be useful in the management of diseases related to tissue wastage such as cardiomyopathy and nephropathy which are associated with Type 2 diabetes mellitus.

1 May 2019 in Journal of Infection and Public Health
Verified
Journal Article
Open access
AMAnshuman Mishra
Anshuman Mishra
PSPandarisamy Sundaravadivel
Pandarisamy Sundaravadivel
STSunil Kumar Tripathi
Sunil Kumar Tripathi
RJRAJAN Kumar JHA
RAJAN Kumar JHA
JBJaydeep Badrukhiya
Jaydeep Badrukhiya
KTKumarasamy Thangaraj
Kumarasamy Thangaraj
The host genetic factors play important role in determining the outcome of visceral leishmaniasis (VL). Macrophage migration inhibitory factor (MIF) is an important host cytokine, which is a key regulator of innate immune system. Genetic variants in MIF gene have been found to be associated with several inflammatory and infectious diseases. Role of MIF is well documented in leishmaniasis diseases, including Indian visceral leishmaniasis, where elevated level of serum MIF has been associated with VL phenotypes. However, there was no genetic study to correlate MIF variants in VL, therefore, we aimed to study the possible association of three reported MIF gene variants -794 CATT, -173G > C and non-coding RNA gene LOC284889 in Indian VL phenotype. Study subjects comprised of 214 VL patients along with ethnically and demographically matched 220 controls from VL endemic regions of Bihar state in India. We found no significant difference between cases and controls in allelic, genotypic and haplotype frequency of the markers analysed [-794 CATT repeats (χ2=0.86; p=0.35; OR=0.85; 95% CI=0.61-1.19); -173 G>C polymorphism (χ2=1.11; p=0.29; OR=0.83; 95% CI=0.59-1.16); and LOC284889 (χ2=0.78; p=0.37; OR=0.86; 95% CI=0.61-1.20)]. Since we did not find any significant differences between case and control groups, we conclude that sequencing of complete MIF gene and extensive study on innate and adaptive immunity genes may help in identifying genetic variations that are associated with VL susceptibility/resistance among Indians.